- 1、本文档共60页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
February 2006
EP32-R
Metrological Traceability and Its
Implementation; A Report
This document provides guidance to manufacturers for
establishing and reporting metrological traceability.
A CLSI report for global application.
Clinical and Laboratory Standards Institute
Setting the standard for quality in clinical laboratory testing around the world.
The Clinical and Laboratory Standards Institute (CLSI) is a not-for-profit membership organization that brings
together the varied perspectives and expertise of the worldwide laboratory community for the advancement of
a common cause: to foster excellence in laboratory medicine by developing and implementing clinical laboratory
standards and guidelines that help laboratories fulfill their responsibilities with efficiency, effectiveness, and
global applicability.
Consensus Process
Consensus—the substantial agreement by materially affected, competent, and interested parties—is core to the
development of all CLSI documents. It does not always connote unanimous agreement, but does mean that the
participants in the development of a consensus document have considered and resolved all relevant objections
and accept the resulting agreement.
Commenting on Documents
CLSI documents undergo periodic evaluation and modification to keep pace with advancements in technologies,
procedures, methods, and protocols affecting the laboratory or health care.
CLSI’s consensus process depends on experts who volunteer to serve as contributing authors and/or as
participants in the reviewing and commenting process. At the end of each comment period, the committee that
developed the document is obligated to review all comments, respond in writing to all substantive comments,
and revise the draft document as appropriate.
Comments on published CLSI documents are equally essential, and may be submitted by anyone, at any time, on
any d
您可能关注的文档
- 国产普通化妆品备案 - 办事指南.doc
- CAP MOL Sep07 实验室认证程序 分子病理学检查表.pdf
- CLSI EP06-A-2003 用统计方法评价定量测量程序的线性度.pdf
- CLSI EP09 A3 方法学对比与患者样本偏倚估计 第3版.pdf
- CLSI EP09-A2-IR 方法学对比与患者样本偏倚估计 第2版.doc
- CLSI EP09-A2-IR 方法学对比与患者样本偏倚估计 第2版.pdf
- CLSI EP09-A3 用患者样本进行方法比对及偏倚估.pdf
- CLSI EP09-A3-2013 方法学对比与患者样本偏倚估计 第3版.pdf
- CLSI EP10-A2 定量临床检验方法的初步评价:批准指南(1998)。.pdf
- CLSI EP10-A3 临床实验室定量测量程序的初步评价 第3版.pdf
文档评论(0)